Transverse vs Longitudinal Incision in Myomectomy

The Aim of the study is to compare between transverse and longitudinal uterine incision in abdominal myomectomy regarding intraoperative blood loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myoma;Uterus Connective Tissue Diseases Myofibroma Neoplasms Neoplasms by Histologic Type Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Skin and Connective Tissue Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Inclusion criteria for myomectomy as; abnormal uterine, pressure related symptoms, infertility and recurrent pregnancy loss in patients between 18 and 45 years old
Single myoma.
Women with BMI between 18.5-29.9 kg/m2.

Exclusion criteria

Pregnancy.
Patients with bleeding tendency
Previous laparotomies.
Patients with concomitant pelvic pathologies, such as ovarian cysts.

Treatment and study plan

Longitudinal uterine incision

Procedure

Transverse uterine incision

Procedure

Primary outcomes

Intraoperative blood loss

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Transverse Versus Longitudinal Uterine Incision in Abdominal Myomectomy

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Jan 4, 2017
Registry last updated: Apr 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed